Studying the Clinical Trial Experiences of Patients With Mesothelioma

April 21, 2023

Primary Outcome Measures

Rate of patients who decide to enroll in a mesothelioma medical study. [ Time Frame: 3 months ]
Number of mesothelioma patients who remain in clinical trial until completion. [ Time Frame: 12 months ]

Inclusion Criteria

Must have a medical diagnosis of mesothelioma that has been confirmed by a physician.
Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria

Pregnant or lactating woman
Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
Known medical condition that, in the investigator’s opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results

CONTACT INFORMATION

Name*

First Last

Email*

Phone*

Address*

Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country

Have you received a diagnosis?*

Yes

DIAGNOSIS

Diagnosis?*

Date of Diagnosis*

Comments*

Name

This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact